SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlations.

Archive ouverte

Millecamps, Stéphanie | Salachas, François | Cazeneuve, Cécile | Gordon, Paul | Bricka, Bernard | Camuzat, Agnès | Guillot-Noël, Léna | Russaouen, Odile | Bruneteau, Gaëlle | Pradat, Pierre-François | Le Forestier, Nadine | Vandenberghe, Nadia | Danel-Brunaud, Véronique | Guy, Nathalie | Thauvin-Robinet, Christel | Lacomblez, Lucette | Couratier, Philippe | Hannequin, Didier | Seilhean, Danielle | Le Ber, Isabelle | Corcia, Philippe | Camu, William | Brice, Alexis | Rouleau, Guy | Leguern, Eric | Meininger, Vincent

Edité par CCSD ; BMJ Publishing Group -

International audience. BACKGROUND: Mutations in SOD1, ANG, VAPB, TARDBP and FUS genes have been identified in amyotrophic lateral sclerosis (ALS). METHODS: The relative contributions of the different mutations to ALS were estimated by systematically screening a cohort of 162 families enrolled in France and 500 controls (1000 chromosomes) using molecular analysis techniques and performing phenotype-genotype correlations. RESULTS: 31 pathogenic missense mutations were found in 36 patients (20 SOD1, 1 ANG, 1 VAPB, 7 TARDBP and 7 FUS). Surprisingly two FUS mutation carriers also harboured ANG variants. One family of Japanese origin with the P56S VAPB mutation was identified. Seven novel mutations (three in SOD1, two in TARDBP, two in FUS) were found. None of them was detected in controls. Segregation of detected mutations with the disease was confirmed in 11 families including five pedigrees carrying the novel mutations. Clinical comparison of SOD1, TARDBP, FUS and other familial ALS patients (with no mutation in the screened genes) revealed differences in site of onset (predominantly lower limbs for SOD1 and upper limbs for TARDBP mutations), age of onset (younger with FUS mutations), and in lifespan (shorter for FUS carriers). One third of SOD1 patients survived more than 7 years: these patients had earlier disease onset than those presenting with a more typical course. Differences were also observed among FUS mutations, with the R521H FUS mutation being associated with longer disease duration. CONCLUSIONS: This study identifies new genetic associations with ALS and provides phenotype-genotype correlations with both previously reported and novel mutations.

Suggestions

Du même auteur

Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes

Archive ouverte | Millecamps, Stéphanie | CCSD

International audience

C9ORF72 repeat expansions in the frontotemporal dementias spectrum of diseases: a flow-chart for genetic testing.

Archive ouverte | Le Ber, Isabelle | CCSD

International audience. Frontotemporal dementia (FTD) refers to a disease spectrum including the behavioral variant FTD (bvFTD), primary progressive aphasia (PPA), progressive supranuclear palsy/corticobasal degener...

Contribution of ATXN2 intermediary polyQ expansions in a spectrum of neurodegenerative disorders.

Archive ouverte | Lattante, Serena | CCSD

International audience. The aim of this study was to establish the frequency of ATXN2 polyglutamine (polyQ) expansion in large cohorts of patients with amyotrophic lateral sclerosis (ALS), frontotemporal dementia (F...

Chargement des enrichissements...